Is Adverum Biotechnologies Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ADVM) stock is to Strong Buy ADVM stock.
Out of 3 analysts, 2 (66.67%) are recommending ADVM as a Strong Buy, 0 (0%) are recommending ADVM as a Buy, 1 (33.33%) are recommending ADVM as a Hold, 0 (0%) are recommending ADVM as a Sell, and 0 (0%) are recommending ADVM as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year ADVM price target, the average ADVM price target is $33.33, with the highest ADVM stock price forecast at $40.00 and the lowest ADVM stock price forecast at $20.00.
On average, Wall Street analysts predict that Adverum Biotechnologies's share price could reach $33.33 by Mar 19, 2025. The average Adverum Biotechnologies stock price prediction forecasts a potential upside of 203.03% from the current ADVM share price of $11.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.